Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: A multiinstitutional experience

International Journal of Gynecological Cancer

Volumn 17, Issue 4, 2007, Pages 886-889

  Huh, W K ^a   Straughn Jr , J M ^a   Mariani, A ^b   Podratz, K C ^b   Havrilesky, L J ^c   Alvarez Secord, A ^c   Gold, M A ^d   McMeekin, D S ^d   Modesitt, S ^e   Cooper, A L ^e   Powell, M A ^f   Mutch, D G ^f   Nag, S ^g   Alvarez, R D ^a   Cohn, D E ^g  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MAYO CLINIC   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g OHIO STATE UNIVERSITY   (United States)

Author keywords

Endometrial cancer; Recurrence; Salvage; Vaginal

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CYTOLOGY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HYSTERECTOMY; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; RISK FACTOR; SALPINGOOOPHORECTOMY; SALVAGE THERAPY; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS; TREATMENT OUTCOME; VAGINA CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK FACTORS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 34447300477     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00858.x     Document Type: Article

References (12)

1. The American Cancer Society. Cancer facts and figures 2005. Available at: http://www.cancer.org accessed July, 2005)
2. Ingersoll FM. Vaginal recurrence of carcinoma of the corpus: management and prevention. Am J Surg 1971 121: 473 7.
3. Creutzberg CL, van Putten WL, Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage I endometrial carcinoma: multicentre randomized trial. Lancet 2000 355: 1404 11.
4. Aalders JG, Abeler V, Kolstad P. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980 56: 419 27.
5. Keys HM, Roberts JA, Brunetto VL et al. A Phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2003 92: 744 51.
6. Straughn JM, Huh WK, Kelly JF et al. Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 2001 84: 194 200.
7. Straughn JM, Huh WK, Orr JW et al. Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol 2003 89: 295 300.
8. Ayhan A, Taskiran C, Celik C et al. Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer? Gynecol Oncol 2002 86: 259 63.
9. Jhingran A, Burke TW, Eifel PJ. Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 2003 56: 1366 72.
10. Maxwell GL, Risinger JI, Hayes KA et al. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers. Clin Cancer Res 2000 6: 2999 3005.
11. Clifford SI, Kaminetsky CP, Cirisano FD et al. Racial disparity in overexpression of the p53 tumor suppressor gene in stage I endometrial cancer. Am J Obstet Gynecol 1997 176: S229 32.
12. Hill HA, Eley JW, Harlan LC, Greenberg RS, Barrett RJ, Chen VW. Racial differences in endometrial cancer survival: the black/white cancer survival study. Obstet Gynecol 1996 88: 919 26.